Proinflammatory Factors Mediate Paclitaxel-Induced Impairment of Learning and Memory
Authors:
Open Access
- 22 February 2018
- journal article
- research article
- Published by Wiley in Mediators of Inflammation
- Vol. 2018, 1-9
Abstract
The chemotherapeutic agent paclitaxel is widely used for cancer treatment. Paclitaxel treatment impairs learning and memory function, a side effect that reduces the quality of life of cancer survivors. However, the neural mechanisms underlying paclitaxel-induced impairment of learning and memory remain unclear. Paclitaxel treatment leads to proinflammatory factor release and neuronal apoptosis. Thus, we hypothesized that paclitaxel impairs learning and memory function through proinflammatory factor-induced neuronal apoptosis. Neuronal apoptosis was assessed by TUNEL assay in the hippocampus. Protein expression levels of tumor necrosis factor-α(TNF-α) and interleukin-1β(IL-1β) in the hippocampus tissue were analyzed by Western blot assay. Spatial learning and memory function were determined by using the Morris water maze (MWM) test. Paclitaxel treatment significantly increased the escape latencies and decreased the number of crossing in the MWM test. Furthermore, paclitaxel significantly increased the number of TUNEL-positive neurons in the hippocampus. Also, paclitaxel treatment increased the expression levels of TNF-αand IL-1βin the hippocampus tissue. In addition, the TNF-αsynthesis inhibitor thalidomide significantly attenuated the number of paclitaxel-induced TUNEL-positive neurons in the hippocampus and restored the impaired spatial learning and memory function in paclitaxel-treated rats. These data suggest that TNF-αis critically involved in the paclitaxel-induced impairment of learning and memory function.Keywords
Funding Information
- Natural Science Foundation of Hebei Province (H2013206087, 81371231)
- National Natural Science Foundation of China (H2013206087, 81371231)
This publication has 62 references indexed in Scilit:
- Sustained, neuron-specific IKK/NF-κB activation generates a selective neuroinflammatory response promoting local neurodegeneration with agingMolecular Neurodegeneration, 2013
- Radiation/Paclitaxel Treatment of p53-Abnormal Non-Small Cell Lung Cancer Xenograft Tumor and Associated MechanismCancer Biotherapy and Radiopharmaceuticals, 2012
- Prevalence of Self-Reported Memory Problems in Adult Cancer Survivors: A National Cross-Sectional StudyJournal of Oncology Practice, 2012
- Early, progressive, and sustained dysfunction of sensory axons underlies paclitaxel‐induced neuropathyMuscle & Nerve, 2010
- Paclitaxel Potentiates Inflammatory Cytokine-induced Prothrombotic Molecules in Endothelial CellsJournal of Cardiovascular Pharmacology, 2010
- Parkin regulates paclitaxel sensitivity in breast cancer via a microtubule‐dependent mechanismThe Journal of Pathology, 2009
- Candidate mechanisms for chemotherapy-induced cognitive changesNature Reviews Cancer, 2007
- Paclitaxel- and vincristine-evoked painful peripheral neuropathies: Loss of epidermal innervation and activation of Langerhans cellsExperimental Neurology, 2006
- Peripheral neuropathy: A persisting challenge in paclitaxel-based regimesEuropean Journal of Cancer, 2006
- Oligodendrocyte Apoptosis and Primary Demyelination Induced by Local TNF/p55TNF Receptor Signaling in the Central Nervous System of Transgenic MiceThe American Journal of Pathology, 1998